NSEOutcome of Board Meeting28 Sept 2026 · 28 Sept 2026, 08:55 pm

Outcome of Board Meeting

Bliss GVS Pharma Limited · BLISSGVS

✦ AI SummaryPromoter Reclassif.

Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of the 2nd Board Meeting held on September 28, 2026, where the Board has taken note of the re-classification of the erstwhile members of the promoter and promoter group of the Company from the “promoter/promoter group” category to the “public” category, in accordance with Regulation 31A(10) of the SEBI Listing Regulations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of the 2nd Board Meeting held on September 28, 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category to the "public" category.

Attachments (1)

📄

BLISSGVS_28092026205539_Outcome___BM___Bliss_GVS___2ndBM.pdf

pdf

Download →
View document text
September 28, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Outcome of board meeting pursuant to Regulation 30 read with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Ref: Regulation 31A(10) of the SEBI Listing Regulations in relation to re-classification from the “promoter and promoter group” category to the “public” category. Pursuant to Regulations 30 and 31A(10) read with Schedule III of the SEBI Listing Regulations, we wish to inform you that the board of directors of Bliss GVS Pharma Limited (the “Company”), at its meeting held today, i.e. Monday, September 28, 2026, has, inter alia, taken note of the consummation of the transaction contemplated under the share purchase agreement dated May 23, 2026 (“SPA”), entered into amongst Anupam Rasayan India Limited (“Purchaser”), the Sellers (as defined therein) read with the deed of adherence dated July 17, 2026 (“DOA”) executed between Mates Visa Consultancy Private Limited (“PAC”) and the Purchaser whereby the Purchaser had assigned its rights under the SPA to PAC (collectively, “Transaction Documents”). Pursuant to the consummation of the underlying transaction contemplated under the Transaction Documents on September 28, 2026, (including the transfer of the equity shares held by the Promoter Sellers (as defined in the SPA) to the Purchaser/PAC) and completion of the open offer made by the Purchaser in accordance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended and the consequent acquisition of control of the Company by the Purchaser/PAC, the Board has taken note of the re-classification of the erstwhile members of the promoter and promoter group of the Company from the “promoter/promoter group” category to the “public” category, in accordance with Regulation 31A(10) of the SEBI Listing Regulations. Accordingly, the details of the Promoters and Promoter Group members who have ceased to be in control of the Company and stand re-classified from the “promoter/promoter group” category to the “public” category pursuant to Regulation 31A(10) of the SEBI Listing Regulations (collectively referred to as the “Outgoing Promoters”) are set out below: Promoters and Promoters group reclassifying as public Category No. Name of No. of % of No. of % of Persons equity shareholding equity Shareholding shares held prior to shares Held post prior to Completion post Completion Completion Completion 1. Shruti Vishal Rao 21,10,000 1.98% Nil 0.00% 2. Vibha Gagan 25,75,000 2.42% Nil 0.00% Sharma 3. Narsimha 3,24,37,024 30.51% Nil 0.00% Shibroor Kamath 4. Gagan Harsh Nil 0.00% Nil 0.00% Sharma 5. Shibroor Gokuldas 8,000 0.01% 8,000 0.01% Kamath 6. Ramdas Vasudev Kamath 100 0.00% 100 0.00% 7. Punita Sharma Nil 0.00% Nil 0.00% 8. Ramdas Nil 0.00% Nil 0.00% Vasudev Kamath 9. Geeta Narsimha Nil 0.00% Nil 0.00% Kamath 10. Shibroor Ravidas Nil 0.00% Nil 0.00% Kamath 11. Vishal Vijay Rao Nil 0.00% Nil 0.00% 12. Shiv Kumar Nil 0.00% Nil 0.00% Sharma 13. Radha Sharma Nil 0.00% Nil 0.00% 14. Shagun Sharma Nil 0.00% Nil 0.00% 15. Lalneet Sharma Nil 0.00% Nil 0.00% 16. Vijay Bhawanishanker Nil 0.00% Nil 0.00% 17. Meera Vijay Rao Nil 0.00% Nil 0.00% 18. Radha Nayak Nil 0.00% Nil 0.00% 19. Jagdishchandra Nil 0.00% Nil 0.00% Dhutia 20. Rajendra Bhatia Nil 0.00% Nil 0.00% 21. Madhuri Nil 0.00% Nil 0.00% Naygandhi 22. Lalita Bhatia Nil 0.00% Nil 0.00% 23. Vinita Siddhesh Nil 0.00% Nil 0.00% Shenoy 24. GVSK LLP Nil 0.00% Nil 0.00% 25. GNR Enterprises Nil 0.00% Nil 0.00% 26. Aayushi Realtors Nil 0.00% Nil 0.00% 27. Keetup India Nil 0.00% Nil 0.00% Private Limited Total 3,71,30,124 34.82% 8,100 0.01% In this regard, we wish to further inform you that: 1. The intent of the Outgoing Promoters to cease to be promoters/promoter group members of the Company pursuant to consummation of the transaction envisaged under the SPA and to be reclassified from the “promoter” category to the “public” category in accordance with Regulation 31A(10) of the Listing Regulations was, inter alia, specifically disclosed in the letter of offer dated 18 July 2026 (“LOF”) issued by the Incoming Promoter in relation to the open offer made in accordance with the Takeover Regulations. Paragraphs 6 of Section III(A) (Background to the Open Offer) and paragraph 3 of Section VI (Background of the Sellers) of the LOF, inter alia, state that pursuant to the consummation of the transaction contemplated in the SPA, the Outgoing Promoters shall cease to be in control of the Company and will be re- classified from the “promoter” category of the Company to the “public” category with effect from, and immediately upon, the consummation of the SPA, in accordance with the Listing Regulations. 2. The Outgoing Promoters have confirmed compliance with Regulation 31A(3)(b) of the Listing Regulations and undertaken to comply with the requirements under Regulation 31A(4) of the Listing Regulations. 3. The Company is in compliance with sub-clauses (c)(ii) and (c)(iii) of sub-regulation (3) of Regulation 31(A) of the Listing Regulations. The meeting of the Board of Directors commenced at 07:05 p.m. and concluded at 07:18 p.m. Kindly take the above information on your record and acknowledge. Thanking you, Yours Faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary & Compliance Officer